OLEMA PHARMACEUTICALS, INC. (OLMA) Net income 2019–2025
OLEMA PHARMACEUTICALS, INC. (OLMA) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$162.5MFY2025 · since FY2019: -$4.3M → -$162.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.5M | -25.5% |
| FY2024 | -$129.5M | -34.0% |
| FY2023 | -$96.7M | +7.8% |
| FY2022 | -$104.8M | -47.4% |
| FY2021 | -$71.1M | -221.4% |
| FY2020 | -$22.1M | -412.5% |
| FY2019 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OLMA financial trends
OLMA RevenueOLMA Net marginOLMA Gross profitOLMA Gross marginOLMA Operating incomeOLMA Operating marginOLMA Operating cash flowOLMA Free cash flowOLMA Capital expendituresOLMA Return on equityOLMA Stock buybacksOLMA Dividends paidOLMA Total assetsOLMA Total liabilitiesOLMA Shareholders’ equityOLMA overview →